ParkerVision, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 10, 2026, reporting a net income of $903 thousand for the third quarter driven primarily by a change in fair value of contingent payment obligations.
Key Highlights
- Q3 net income of $903 thousand: compared to a net loss of $1,966 thousand in the same quarter of 2025, according to the filing.
- Nine-month net loss of $502 thousand: for the nine months ended September 30, 2026, versus a net loss of $7,399 thousand in the prior-year period.
- Fair value gain of $3,381 thousand: change in fair value of contingent payment obligations for the nine months ended September 30, 2026, was the primary driver of other income.
- Cash and cash equivalents of $1,642 thousand: as of September 30, 2026, down from $4,360 thousand at December 31, 2025.
- Total shareholders' deficit of $43,491 thousand: as of September 30, 2026, compared to a deficit of $45,104 thousand at December 31, 2025.
- 148,251 thousand shares outstanding: as of September 30, 2026, up from 143,156 thousand at December 31, 2025.
- Zero licensing revenue: reported for both the three-month and nine-month periods ended September 30, 2026 and 2025.
ParkerVision's Q3 2026 Financials: Fair Value Shifts and Continued Deficit
According to the filing, ParkerVision reported net income of $903 thousand for the three months ended September 30, 2026, a reversal from the net loss of $1,966 thousand recorded in the same period of 2025. The company disclosed that the primary contributor to this result was a $2,055 thousand gain in the change in fair value of contingent payment obligations for the quarter, compared to a loss of $357 thousand on the same line item in Q3 2025. The company reported no licensing revenue in either period.
For the nine months ended September 30, 2026, the filing reports a net loss of $502 thousand, sharply reduced from the $7,399 thousand net loss in the nine months ended September 30, 2025. Selling, general, and administrative expenses for the nine-month period were $3,558 thousand, compared to $6,590 thousand in the prior-year period. Net cash used in operating activities was $2,548 thousand for the nine months ended September 30, 2026, versus $4,071 thousand in the comparable 2025 period. The company also reported a loss on extinguishment of debt of $131 thousand for the nine-month period in 2026, with no comparable figure in 2025.
The balance sheet as of September 30, 2026, showed total assets of $2,767 thousand and total liabilities of $46,258 thousand, resulting in a total shareholders' deficit of $43,491 thousand. The filing identifies long-term liabilities totaling $43,308 thousand, which include a secured contingent payment obligation of $36,733 thousand and unsecured contingent payment obligations of $5,975 thousand. The accumulated deficit stood at $456,110 thousand as of September 30, 2026. The cover page of the filing states that as of November 5, 2026, 149,246,616 shares of common stock were outstanding. The securities registered table on the cover page lists no exchange or trading symbol under Section 12(b).
What Was Disclosed
ParkerVision filed a Form 10-Q for the quarter ended September 30, 2026, disclosing a third-quarter net income of $903 thousand, a nine-month net loss of $502 thousand, zero licensing revenue, declining cash, and a total shareholders' deficit of $43,491 thousand.



Please wait processing your request...